Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H28N4O3 |
| Molecular Weight | 396.4827 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC=C(CC2=NC3=C(C=CC(=C3)[N+]([O-])=O)N2CCN(CC)CC)C=C1
InChI
InChIKey=PXDBZSCGSQSKST-UHFFFAOYSA-N
InChI=1S/C22H28N4O3/c1-4-24(5-2)13-14-25-21-12-9-18(26(27)28)16-20(21)23-22(25)15-17-7-10-19(11-8-17)29-6-3/h7-12,16H,4-6,13-15H2,1-3H3
Etonitazene is a potent and selective mu-opioid agonist. It was developed in CIBA. Administration of etonitazene may induce respiratory depression, and therefor etonitazene is not used in humans. Etonitazene is explicitly listed as an illegal drug under UN convention and is illegal throughout the world.
CNS Activity
Originator
Approval Year
Sample Use Guides
In rat tail-withdrawal assay, etonitazene was administered subcutaneously. ED50 was 0.38 mg/kg.
Route of Administration:
Other
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9624
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-Etonitazene
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ETONITAZENE
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
DB01462
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
m5197
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
13493
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
100000082109
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
C084835
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
9U3GT3353T
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
1073
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL312040
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
SUB07334MIG
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
911-65-9
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
C65596
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
DTXSID6048919
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY | |||
|
213-009-1
Created by
admin on Mon Mar 31 18:21:04 GMT 2025 , Edited by admin on Mon Mar 31 18:21:04 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PARENT)
SALT/SOLVATE (PARENT)
